Drug of Abuse Testing Market Size, Share & Trends Analysis Report 2025-2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	250 Pages	Acumen Research and Consulting	March, 2025	ACRC19876741

Best Price Guarantee
Price	from $4,500
Length	250 Pages
Publisher	Acumen Research and Consulting
Published Date	March, 2025
SKU	ACRC19876741

The Global Drug of Abuse Testing Market Size accounted for USD 7.05 Billion in 2024 and is estimated to achieve a market size of USD 12.46 Billion by 2033 growing at a CAGR of 6.7% from 2025 to 2033.

The drug of abuse testing market refers to the industry involved in the detection of illicit drug use or abuse through various diagnostic tools and technologies. This market serves a wide range of applications, from law enforcement and workplace drug testing to clinical and rehabilitation settings. As the global prevalence of drug abuse continues to rise, the demand for accurate, rapid, and reliable drug testing solutions has surged. This abstract delves into the current trends, market drivers, key challenges, opportunities, and future projections within the drug of abuse testing industry.

Drug abuse is a growing concern worldwide, with rising rates of addiction to substances such as opioids, cocaine, cannabis, amphetamines, and prescription medications. The increase in drug-related deaths and the escalating societal burden of substance abuse are prompting governments, healthcare providers, employers, and law enforcement agencies to invest in effective drug testing methods. These tests play a crucial role in detecting illicit drug use, monitoring individuals in treatment programs, ensuring workplace safety, and preventing criminal activity related to drug consumption.

Drug of Abuse Testing Market Segmentation

The worldwide market for drug of abuse testing is split based on drug type, product, sample type, end-user, and geography.

Drug of Abuse Testing Market By Drug Type
Alcohol
LSD
Cocaine
Opioids
Marijuana/Cannabis
Amphetamine & Methamphetamine
Others

Drug of Abuse Testing Market By Product

Equipment
Immunoassay Analyzers
Breath Analyzers
Chromatography Instruments
Consumables
Reagents
Rapid Test Kits
Others

Drug of Abuse Testing Market By Sample Type

Urine
Breath
Saliva
Blood
Hair
Others

Drug of Abuse Testing End-user

Hospitals
Workplaces
Research Labs
Criminal Justice Systems

Drug of Abuse Testing Market Regional Outlook

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of LATAM
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Drug of Abuse Testing Market Players

Some of the top drug of abuse testing companies offered in our report includes DrugScan, Mayo Clinic Laboratories, Danaher Corporation, Precision Diagnostics, Cordant Health Solutions, LabCorp, Abbott Laboratories, Quest Diagnostics, Inc., LGC Group, and Legacy Medical Services.

CHAPTER 1.Industry Overview of Drug of Abuse Testing Market: 1.1.Definition and Scope; 1.2.Summary
CHAPTER 2.Research Approach: 2.1.Methodology; 2.2.Data Source
CHAPTER 3.Market Dynamics And Competition Analysis: 3.1.Market Drivers; 3.2.Restraints and Challenges; 3.3.Growth Opportunities; 3.4.Porter’s Five Forces Analysis; 3.4.1.Bargaining Power of Suppliers; 3.4.2.Bargaining Power of Buyers; 3.4.3.Threat of Substitute; 3.4.4.Threat of New Entrants; 3.4.5.Degree of Competition; 3.5.Market Concentration Ratio and Market Maturity Analysis of Drug of Abuse Testing Market; 3.5.1.Go To Market Strategy; 3.5.1.1.Introduction; 3.5.1.2.Growth; 3.5.1.3.Maturity; 3.5.1.4.Saturation; 3.5.1.5.Possible Development; 3.6.Technological Roadmap for Drug of Abuse Testing Market; 3.7.Value Chain Analysis; 3.7.1.List of Key Manufacturers; 3.7.2.List of Customers; 3.7.3.Level of Integration; 3.8.Cost Structure Analysis; 3.8.1.Price Trend of Key Raw Materials; 3.8.2.Raw Material Suppliers; 3.8.3.Proportion of Manufacturing Cost Structure; 3.8.3.1.Raw Material; 3.8.3.2.Labor Cost; 3.8.3.3.Manufacturing Expense; 3.9.Regulatory Compliance; 3.10.Competitive Landscape, 2024; 3.10.1.Player Positioning Analysis; 3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis: 4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2024; 4.2.R&D Status of Major Manufacturers in 2024
CHAPTER 5.Drug of Abuse Testing Market By Drug Type: 5.1.Introduction; 5.2.Drug of Abuse Testing Revenue By Drug Type; 5.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Drug Type, 2021-2033; 5.2.2.Alcohol; 5.2.2.1.Alcohol Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.3.LSD; 5.2.3.1.LSD Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.4.Cocaine; 5.2.4.1.Cocaine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.5.Opioids; 5.2.5.1.Opioids Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.6.Marijuana/Cannabis; 5.2.6.1.Marijuana/Cannabis Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.7.Amphetamine & Methamphetamine; 5.2.7.1.Amphetamine & Methamphetamine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.8.Others; 5.2.8.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 6.Drug of Abuse Testing Market By Product: 6.1.Introduction; 6.2.Drug of Abuse Testing Revenue By Product; 6.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Product, 2021-2033; 6.2.2.Equipment; 6.2.2.1.Equipment Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.2.2.Immunoassay Analyzers; 6.2.2.2.1.Immunoassay Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.2.3.Breath Analyzers; 6.2.2.3.1.Breath Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.2.4.Chromatography Instruments; 6.2.2.4.1.Chromatography Instruments Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.3.Consumables; 6.2.3.1.Consumables Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.3.2.Reagents; 6.2.3.2.1.Reagents Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.3.3.Rapid Test Kits; 6.2.3.3.1.Rapid Test Kits Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.3.4.Others; 6.2.3.4.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 7.Drug of Abuse Testing Market By Sample Type: 7.1.Introduction; 7.2.Drug of Abuse Testing Revenue By Sample Type; 7.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Sample Type, 2021-2033; 7.2.2.Urine; 7.2.2.1.Urine Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.3.Breath; 7.2.3.1.Breath Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.4.Saliva; 7.2.4.1.Saliva Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.5.Blood; 7.2.5.1.Blood Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.6.Hair; 7.2.6.1.Hair Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.7.Others; 7.2.7.1.Others Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 8.Drug of Abuse Testing Market By End-user: 8.1.Introduction; 8.2.Drug of Abuse Testing Revenue By End-user; 8.2.1.Drug of Abuse Testing Revenue (USD Billion) and Forecast, By End-user, 2021-2033; 8.2.2.Hospitals; 8.2.2.1.Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 8.2.3.Workplaces; 8.2.3.1.Workplaces Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 8.2.4.Research Labs; 8.2.4.1.Research Labs Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 8.2.5.Criminal Justice Systems; 8.2.5.1.Criminal Justice Systems Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 9.North America Drug of Abuse Testing Market By Country: 9.1.North America Drug of Abuse Testing Market Overview; 9.2.U.S.; 9.2.1.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 9.2.2.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 9.2.3.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 9.2.4.U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End-Use, 2021-2033; 9.3.Canada; 9.3.1.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 9.3.2.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 9.3.3.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 9.3.4.Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 9.4.North America PEST Analysis
CHAPTER 10.Europe Drug of Abuse Testing Market By Country: 10.1.Europe Drug of Abuse Testing Market Overview; 10.2.U.K.; 10.2.1.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 10.2.2.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 10.2.3.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 10.2.4.U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.3.Germany; 10.3.1.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 10.3.2.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 10.3.3.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 10.3.4.Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.4.France; 10.4.1.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 10.4.2.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 10.4.3.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 10.4.4.France Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.5.Spain; 10.5.1.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 10.5.2.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 10.5.3.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 10.5.4.Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.6.Rest of Europe; 10.6.1.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 10.6.2.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 10.6.3.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 10.6.4.Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.7.Europe PEST Analysis
CHAPTER 11.Asia Pacific Drug of Abuse Testing Market By Country: 11.1.Asia Pacific Drug of Abuse Testing Market Overview; 11.2.China; 11.2.1.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.2.2.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.2.3.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.2.4.China Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.3.Japan; 11.3.1.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.3.2.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.3.3.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.3.4.Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.4.India; 11.4.1.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.4.2.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.4.3.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.4.4.India Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.5.Australia; 11.5.1.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.5.2.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.5.3.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.5.4.Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.6.South Korea; 11.6.1.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.6.2.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.6.3.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.6.4.South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.7.Rest of Asia-Pacific; 11.7.1.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 11.7.2.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 11.7.3.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 11.7.4.Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.8.Asia Pacific PEST Analysis
CHAPTER 12.Latin America Drug of Abuse Testing Market By Country: 12.1.Latin America Drug of Abuse Testing Market Overview; 12.2.Brazil; 12.2.1.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 12.2.2.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 12.2.3.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 12.2.4.Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.3.Mexico; 12.3.1.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 12.3.2.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 12.3.3.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 12.3.4.Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.4.Rest of Latin America; 12.4.1.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 12.4.2.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 12.4.3.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 12.4.4.Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.5.Latin America PEST Analysis
CHAPTER 13.Middle East & Africa Drug of Abuse Testing Market By Country: 13.1.Middle East & Africa Drug of Abuse Testing Market Overview; 13.2.GCC; 13.2.1.GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 13.2.2.GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 13.2.3.Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 13.2.4.Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.3.South Africa; 13.3.1.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 13.3.2.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 13.3.3.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 13.3.4.South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.4.Rest of Middle East & Africa; 13.4.1.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2021-2033; 13.4.2.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2021-2033; 13.4.3. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2021-2033; 13.4.4.Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.5.Middle East & Africa PEST Analysis
CHAPTER 14.Player Analysis Of Drug of Abuse Testing Market: 14.1.Drug of Abuse Testing Market Company Share Analysis; 14.2.Competition Matrix; 14.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment; 14.2.2.New Product Launches and Product Enhancements; 14.2.3.Mergers And Acquisition In Global Drug of Abuse Testing Market; 14.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15.Company Profile: 15.1.DrugScan; 15.1.1.Company Snapshot; 15.1.2.Business Overview; 15.1.3.Financial Overview; 15.1.3.1.Revenue (USD Billion), 2024; 15.1.3.2.DrugScan 2024 Drug of Abuse Testing Business Regional Distribution; 15.1.4.Product /Service and Specification; 15.1.5.Recent Developments & Business Strategy; 15.2.Mayo Clinic Laboratories; 15.3.Danaher Corporation; 15.4.Precision Diagnostics; 15.5.Cordant Health Solutions; 15.6.LabCorp; 15.7.Abbott Laboratories; 15.8.Quest Diagnostics, Inc.; 15.9.LGC Group; 15.10.Legacy Medical Services